Biopharmaceutical Supply Chain
Re-thinking the Strategic National Stockpile
I recently testified before the U.S. Senate Subcommittee on Homeland Security and Government Affairs, along with three other witnesses. During this testimony, I shared some of the insights I developed working with the Joint Acquisition Task Force as a pro bono […]
Vaccines are the Utility Needed for the Global Economy
In an article in Politico, the (somewhat) obvious point is made that the Biden administration is finally recognizing that there is not enough manufacturing capacity in the US to produce booster shots that will be needed to combat the new […]
Digitizing the COVID Vaccine: India’s Got This Figured Out
I had an opportunity this week to interview Ran Singh, who is the Acting Director for Asia Pac for Audits and Compliance at GlaxoSmithKline. I met Ran through the 360RX Supply Chain Security Conference, held last year. At this meeting, […]
During the Covid Crisis, don’t forget the Opioid Crisis
This week in a remotely conducted hearing in federal court in New Jersey, Purdue Pharma’s chairman, Steve Miller, acknowledged that in order to meet sales goals, the company told the Drug Enforcement Administration that it had created a program to […]
Poole Graduate Joydeep Ganguly believes in a “Goodness Chain” at Gilead Science
We have a lot of remarkable graduates that come out of the halls of Nelson Hall from the Poole College of Management, and one of the ones I have the pleasure to stay in touch with is Joydeep Ganguly. He […]
Healthcare Strategic Stockpile Management Remains a Big Challenge
Beginning in 2015 the National Academies of Sciences, Engineering and Medicine led a standing committee to inform Strategic National Stockpile (SNS) decision-making. This committee included “…state and local public health officials, representatives of medical manufacturing and distribution companies, logistics managers, […]
Needed: A National Governance Framework for Healthcare Supply Chains
The Tragedy of the Commons – A situation in which a shared resource system, where individual users, acting independently according to their own self-interest, behave contrary to the common good of all users by depleting or spoiling the shared resource […]
Coronavirus reminds us to review supply chain continuity plans
The rapid escalation of the Corona virus has now devastated China and other regions, resulting in more than 800 deaths and more than 37,000 cases worldwide. The most critical outcome of this issue is the tragic loss of life, but […]
Risk Management in Contract Pharmaceutical Development: Contract Research Part 2
The second installation in our series on contract management research published by MBA students from my online Contract Management class is by Julia Condit, and focuses on the challenges of managing contracts in the pharmaceutical industry. As pharmaceutical companies go […]
Changing Executive Mindsets on Global Product Integrity: The Fight Against Counterfeiting Is Here to Stay
I recently interviewed the Director of Brand Protection at a large pharmaceutical company, who shared with me the timeline around how his company gradually shifted and changed its views on brand security, and built a business case around the need […]